{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:49:32Z","timestamp":1788493772075,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,25]],"date-time":"2016-07-25T00:00:00Z","timestamp":1469404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,7,25]],"date-time":"2016-07-25T00:00:00Z","timestamp":1469404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Breast cancer remains as a challenging disease with high mortality in women. Increasing evidence points the importance of understanding a crosstalk between breast cancers and immune cells, but little is known about the effect of breast cancer-derived factors on the migratory properties of dendritic cells (DCs) and their consequent capability in inducing T cell immune responses. Utilizing a unique 3D microfluidic device, we here showed that breast cancers (MCF-7, MDA-MB-231, MDA-MB-436 and SK-BR-3)-derived soluble factors increase the migration of DCs toward CCL19. The enhanced migration of DCs was mainly mediated via the highly activated JNK\/c-Jun signaling pathway, increasing their directional persistence, while the velocity of DCs was not influenced, particularly when they were co-cultured with triple negative breast cancer cells (TNBCs or MDA-MB-231 and MDA-MB-436). The DCs up-regulated inflammatory cytokines IL-1\u03b2 and IL-6 and induced T cells more proliferative and resistant against activation-induced cell death (AICD), which secret high levels of inflammatory cytokines IL-1\u03b2, IL-6 and IFN-\u03b3. This study demonstrated new possible evasion strategy of TNBCs utilizing their soluble factors that exploit the directionality of DCs toward chemokine responses, leading to the building of inflammatory milieu which may support their own growth.<\/jats:p>","DOI":"10.1038\/srep30207","type":"journal-article","created":{"date-parts":[[2016,7,25]],"date-time":"2016-07-25T05:06:03Z","timestamp":1469423163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Human breast cancer-derived soluble factors facilitate CCL19-induced chemotaxis of human dendritic cells"],"prefix":"10.1038","volume":"6","author":[{"given":"Hyundoo","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changsik","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enoch","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bongseo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-A","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoonkyung","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seongho","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon-Kyoung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,25]]},"reference":[{"key":"BFsrep30207_CR1","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423\u20131437 (2013).","journal-title":"Nat. Med"},{"key":"BFsrep30207_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10555-011-9279-y","volume":"30","author":"C Sautes-Fridman","year":"2011","unstructured":"Sautes-Fridman, C. et al. Tumor microenvironment is multifaceted. Cancer Metastasis Rev. 30, 13\u201325 (2011).","journal-title":"Cancer Metastasis Rev."},{"key":"BFsrep30207_CR3","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/onc.2009.416","volume":"29","author":"F Pages","year":"2010","unstructured":"Pages, F. et al. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 29, 1093\u20131102 (2010).","journal-title":"Oncogene"},{"key":"BFsrep30207_CR4","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/nm1643","volume":"13","author":"RM Steinman","year":"2007","unstructured":"Steinman, R. M. Lasker Basic Medical Research Award. Dendritic cells: versatile controllers of the immune system. Nat. Med. 13, 1155\u20131159 (2007).","journal-title":"Nat. Med"},{"key":"BFsrep30207_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-immunol-100311-102839","volume":"30","author":"RM Steinman","year":"2012","unstructured":"Steinman, R. M. Decisions about dendritic cells: past, present, and future. Annu. Rev. Immunol. 30, 1\u201322 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"BFsrep30207_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.7150\/jca.5046","volume":"4","author":"Y Ma","year":"2013","unstructured":"Ma, Y., Shurin, G. V., Peiyuan, Z. & Shurin, M. R. Dendritic cells in the cancer microenvironment. J. Cancer 4, 36\u201344 (2013).","journal-title":"J. Cancer"},{"key":"BFsrep30207_CR7","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1126\/science.286.5447.2098","volume":"286","author":"JG Cyster","year":"1999","unstructured":"Cyster, J. G. Chemokines and cell migration in secondary lymphoid organs. Science 286, 2098\u20132102 (1999).","journal-title":"Science"},{"key":"BFsrep30207_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","volume":"392","author":"J Banchereau","year":"1998","unstructured":"Banchereau, J. & Steinman, R. M. Dendritic cells and the control of immunity. Nature 392, 245\u2013252 (1998).","journal-title":"Nature"},{"key":"BFsrep30207_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000658-199707000-00001","volume":"226","author":"MT Lotze","year":"1997","unstructured":"Lotze, M. T. Getting to the source: dendritic cells as therapeutic reagents for the treatment of patients with cancer. Ann. Surg. 226, 1\u20135 (1997).","journal-title":"Ann. Surg."},{"key":"BFsrep30207_CR10","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1158\/0008-5472.CAN-11-4094","volume":"72","author":"SP Kerkar","year":"2012","unstructured":"Kerkar, S. P. & Restifo, N. P. Cellular constituents of immune escape within the tumor microenvironment. Cancer Res. 72, 3125\u20133130 (2012).","journal-title":"Cancer Res."},{"key":"BFsrep30207_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.imlet.2009.09.003","volume":"127","author":"A Lin","year":"2010","unstructured":"Lin, A., Schildknecht, A., Nguyen, L. T. & Ohashi, P. S. Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth. Immunol. Lett. 127, 77\u201384 (2010).","journal-title":"Immunol. Lett."},{"key":"BFsrep30207_CR12","first-page":"1755","volume":"6","author":"B Almand","year":"2000","unstructured":"Almand, B. et al. Clinical significance of defective dendritic cell differentiation in cancer. Clin. Cancer Res. 6, 1755\u20131766 (2000).","journal-title":"Clin. Cancer Res."},{"key":"BFsrep30207_CR13","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1084\/jem.190.10.1417","volume":"190","author":"D Bell","year":"1999","unstructured":"Bell, D. et al. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J. Exp. Med. 190, 1417\u20131426 (1999).","journal-title":"J. Exp. Med."},{"key":"BFsrep30207_CR14","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/sj.bjc.6600132","volume":"86","author":"BJ Coventry","year":"2002","unstructured":"Coventry, B. J., Lee, P. L., Gibbs, D. & Hart, D. N. Dendritic cell density and activation status in human breast cancer - CD1a, CMRF-44, CMRF-56 and CD-83 expression. Br. J. Cancer 86, 546\u2013551 (2002).","journal-title":"Br. J. Cancer"},{"key":"BFsrep30207_CR15","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1038\/sj.bjc.6601243","volume":"89","author":"S Della Bella","year":"2003","unstructured":"Della Bella, S. et al. Altered maturation of peripheral blood dendritic cells in patients with breast cancer. Br. J. Cancer 89, 1463\u20131472 (2003).","journal-title":"Br. J. Cancer"},{"key":"BFsrep30207_CR16","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s00262-003-0485-5","volume":"53","author":"S Satthaporn","year":"2004","unstructured":"Satthaporn, S. et al. Dendritic cells are dysfunctional in patients with operable breast cancer. Cancer Immunol. Immunother. 53, 510\u2013518 (2004).","journal-title":"Cancer Immunol. Immunother."},{"key":"BFsrep30207_CR17","doi-asserted-by":"publisher","first-page":"R5","DOI":"10.1186\/bcr1361","volume":"8","author":"A Pinzon-Charry","year":"2006","unstructured":"Pinzon-Charry, A. et al. Spontaneous apoptosis of blood dendritic cells in patients with breast cancer. Breast Cancer Res. 8, R5 (2006).","journal-title":"Breast Cancer Res."},{"key":"BFsrep30207_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/(SICI)1097-0215(19990621)84:3<309::AID-IJC19>3.0.CO;2-3","volume":"84","author":"L Lespagnard","year":"1999","unstructured":"Lespagnard, L. et al. Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome. Int. J. Cancer 84, 309\u2013314 (1999).","journal-title":"Int. J. Cancer"},{"key":"BFsrep30207_CR19","first-page":"45","volume":"42","author":"K Wojas","year":"2004","unstructured":"Wojas, K., Tabarkiewicz, J., Jankiewicz, M. & Rolinski, J. Dendritic cells in peripheral blood of patients with breast and lung cancer - a pilot study. Fol. Histochem. Cytobiol. 42, 45\u201348 (2004).","journal-title":"Fol. Histochem. Cytobiol"},{"key":"BFsrep30207_CR20","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1158\/1078-0432.CCR-04-0684","volume":"10","author":"I Treilleux","year":"2004","unstructured":"Treilleux, I. et al. Dendritic cell infiltration and prognosis of early stage breast cancer. Clin. Cancer Res. 10, 7466\u20137474 (2004).","journal-title":"Clin. Cancer Res."},{"key":"BFsrep30207_CR21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrc1670","volume":"5","author":"B Weigelt","year":"2005","unstructured":"Weigelt, B., Peterse, J. L. & van \u2018t Veer, L. J. Breast cancer metastasis: markers and models. Nat. Rev. Cancer 5, 591\u2013602 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"BFsrep30207_CR22","doi-asserted-by":"crossref","unstructured":"Desantis, C., Ma, J., Bryan, L. & Jemal, A. Breast cancer statistics CA: Cancer J. Clin (2013).","DOI":"10.3322\/caac.21203"},{"key":"BFsrep30207_CR23","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10544-012-9733-9","volume":"15","author":"H Hwang","year":"2013","unstructured":"Hwang, H., Park, J., Shin, C., Do, Y. & Cho, Y.-K. Three dimensional multicellular co-cultures and anti-cancer drug assays in rapid prototyped multilevel microfluidic devices. Biomed. Microdevices 15, 627\u2013634 (2013).","journal-title":"Biomed. Microdevices"},{"key":"BFsrep30207_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1039\/C3IB40183A","volume":"6","author":"H Hwang","year":"2014","unstructured":"Hwang, H., Kim, E.-K., Park, J., Suh, P.-G. & Cho, Y.-K. RhoA and Rac1 play independent roles in lysophosphatidic acid-induced ovarian cancer chemotaxis. Integr. Biol. 6, 267\u2013276 (2014).","journal-title":"Integr. Biol."},{"key":"BFsrep30207_CR25","doi-asserted-by":"publisher","first-page":"5614","DOI":"10.1073\/pnas.1014920108","volume":"108","author":"U Haessler","year":"2011","unstructured":"Haessler, U., Pisano, M., Wu, M. & Swartz, M. A. Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19. Proc. Natl. Acad. Sci. USA 108, 5614\u20135619 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep30207_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4049\/jimmunol.1002358","volume":"186","author":"BG Ricart","year":"2011","unstructured":"Ricart, B. G., John, B., Lee, D., Hunter, C. A. & Hammer, D. A. Dendritic Cells Distinguish Individual Chemokine Signals through CCR7 and CXCR4. J. Immunol. 186, 53\u201361 (2011).","journal-title":"J. Immunol."},{"key":"BFsrep30207_CR27","first-page":"529","volume":"8","author":"QL Liu","year":"2009","unstructured":"Liu, Q. L., Wang, Y. S. & Wang, J. X. Effect of insulin on functional status of cord blood-derived dendritic cells and on dendritic cell-induced CTL cytotoxicity against pancreatic cancer cell lines. Hepatobiliary Pancreat. Dis. Int. 8, 529\u2013534 (2009).","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"BFsrep30207_CR28","first-page":"695","volume":"61","author":"P Radwan","year":"2010","unstructured":"Radwan, P., Radwan-Kwiatek, K., Tabarkiewicz, J., Radej, S. & Rolinski, J. Enhanced phenotypic and functional maturation of monocyte-derived dendritic cells from patients with active Crohn\u2019s disease and ulcerative colitis. J. Physiol. Pharmacol. 61, 695\u2013703 (2010).","journal-title":"J. Physiol. Pharmacol."},{"key":"BFsrep30207_CR29","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1093\/intimm\/dxh297","volume":"17","author":"N Iijima","year":"2005","unstructured":"Iijima, N., Yanagawa, Y., Clingan, J. M. & Onoe, K. CCR7-mediated c-Jun N-terminal kinase activation regulates cell migration in mature dendritic cells. Int. Immunol. 17, 1201\u20131212 (2005).","journal-title":"Int. Immunol."},{"key":"BFsrep30207_CR30","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.4049\/jimmunol.174.7.4070","volume":"174","author":"L Riol-Blanco","year":"2005","unstructured":"Riol-Blanco, L. et al. The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed. J. Immunol. 174, 4070\u20134080 (2005).","journal-title":"J. Immunol."},{"key":"BFsrep30207_CR31","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/bcr1746","volume":"9","author":"DG DeNardo","year":"2007","unstructured":"DeNardo, D. G. & Coussens, L. M. Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res. 9, 212 (2007).","journal-title":"Breast Cancer Res."},{"key":"BFsrep30207_CR32","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860\u2013867 (2002).","journal-title":"Nature"},{"key":"BFsrep30207_CR33","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1200\/JCO.2008.18.9068","volume":"27","author":"BL Pierce","year":"2009","unstructured":"Pierce, B. L. et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J. Clin. Oncol. 27, 3437\u20133444 (2009).","journal-title":"J. Clin. Oncol."},{"key":"BFsrep30207_CR34","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nature06175","volume":"449","author":"RM Steinman","year":"2007","unstructured":"Steinman, R. M. & Banchereau, J. Taking dendritic cells into medicine. Nature 449, 419\u2013426 (2007).","journal-title":"Nature"},{"key":"BFsrep30207_CR35","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1084\/jem.20030448","volume":"198","author":"A MartIn-Fontecha","year":"2003","unstructured":"MartIn-Fontecha, A. et al. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198, 615\u2013621 (2003).","journal-title":"J. Exp. Med."},{"key":"BFsrep30207_CR36","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nri1498","volume":"4","author":"D Gabrilovich","year":"2004","unstructured":"Gabrilovich, D. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat. Rev. Immunol. 4, 941\u2013952 (2004).","journal-title":"Nat. Rev. Immunol."},{"key":"BFsrep30207_CR37","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2694","volume":"9","author":"EF Wagner","year":"2009","unstructured":"Wagner, E. F. & Nebreda, A. R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9, 537\u2013549 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"BFsrep30207_CR38","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.1242\/jcs.01481","volume":"117","author":"C Huang","year":"2004","unstructured":"Huang, C., Jacobson, K. & Schaller, M. D. MAP kinases and cell migration. J. Cell Sci. 117, 4619\u20134628 (2004).","journal-title":"J. Cell Sci."},{"key":"BFsrep30207_CR39","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883\u2013899 (2010).","journal-title":"Cell"},{"key":"BFsrep30207_CR40","first-page":"1427","volume":"19","author":"GJ Zhang","year":"1999","unstructured":"Zhang, G. J. & Adachi, I. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res. 19, 1427\u20131432 (1999).","journal-title":"Anticancer Res."},{"key":"BFsrep30207_CR41","first-page":"269","volume":"23","author":"AG Pantschenko","year":"2003","unstructured":"Pantschenko, A. G. et al. The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression. Int. J. Oncol. 23, 269\u2013284 (2003).","journal-title":"Int. J. Oncol."},{"key":"BFsrep30207_CR42","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1158\/0008-5472.CAN-12-4524-T","volume":"73","author":"ZC Hartman","year":"2013","unstructured":"Hartman, Z. C. et al. Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8. Cancer Res. 73, 3470\u20133480 (2013).","journal-title":"Cancer Res."},{"key":"BFsrep30207_CR43","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nature10755","volume":"482","author":"H Matsushita","year":"2012","unstructured":"Matsushita, H. et al. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature 482, 400\u2013404 (2012).","journal-title":"Nature"},{"key":"BFsrep30207_CR44","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.coi.2012.12.003","volume":"25","author":"J Crespo","year":"2013","unstructured":"Crespo, J., Sun, H., Welling, T. H., Tian, Z. & Zou, W. T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment. Curr. Opin. Immunol. 25, 214\u2013221 (2013).","journal-title":"Curr. Opin. Immunol."},{"key":"BFsrep30207_CR45","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nri2742","volume":"10","author":"W Zou","year":"2010","unstructured":"Zou, W. & Restifo, N. P. T(H)17 cells in tumour immunity and immunotherapy. Nature Rev. Immunol. 10, 248\u2013256 (2010).","journal-title":"Nature Rev. Immunol."},{"key":"BFsrep30207_CR46","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1182\/blood-2005-06-2486","volume":"107","author":"S Wang","year":"2006","unstructured":"Wang, S. et al. Tumor evasion of the immune system: inhibiting p38 MAPK signaling restores the function of dendritic cells in multiple myeloma. Blood 107, 2432\u20132439 (2006).","journal-title":"Blood"},{"key":"BFsrep30207_CR47","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.2174\/092986711798347207","volume":"18","author":"KC Sheng","year":"2011","unstructured":"Sheng, K. C., Wright, M. D. & Apostolopoulos, V. Inflammatory mediators hold the key to dendritic cell suppression and tumor progression. Curr. Med. Chem. 18, 5507\u20135518 (2011).","journal-title":"Curr. Med. Chem."},{"key":"BFsrep30207_CR48","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/sj.bjp.0705345","volume":"139","author":"U Oltmanns","year":"2003","unstructured":"Oltmanns, U., Issa, R., Sukkar, M. B., John, M. & Chung, K. F. Role of c-jun N-terminal kinase in the induced release of GM-CSF, RANTES and IL-8 from human airway smooth muscle cells. Br. J. Phamacol. 139, 1228\u20131234 (2003).","journal-title":"Br. J. Phamacol."},{"key":"BFsrep30207_CR49","doi-asserted-by":"publisher","first-page":"6643","DOI":"10.1074\/jbc.M311688200","volume":"279","author":"K Omori","year":"2004","unstructured":"Omori, K., Naruishi, K., Nishimura, F., Yamada-Naruishi, H. & Takashiba, S. High glucose enhances interleukin-6-induced vascular endothelial growth factor 165 expression via activation of gp130-mediated p44\/42 MAPK-CCAAT\/enhancer binding protein signaling in gingival fibroblasts. J. Biol. Chem. 279, 6643\u20136649 (2004).","journal-title":"J. Biol. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep30207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep30207","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep30207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:36:53Z","timestamp":1672879013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep30207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,25]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,7,29]]}},"alternative-id":["BFsrep30207"],"URL":"https:\/\/doi.org\/10.1038\/srep30207","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,25]]},"assertion":[{"value":"16 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30207"}}